Advertisement

Response to HAART according to sex and origin (immigrant vs autochthonous) in a cohort of patients who initiate antiretroviral treatment

  • JA Perez-Molina
  • M Mora-Rillo
  • I Suarez-Lozano
  • JL Casado
  • R Teira
  • P Rivas
  • E Pedrol
  • A Hernando
  • P Domingo
  • E Barquilla
  • H Esteban
  • J Gonzalez-Garcia
Open Access
Poster presentation

Keywords

Public Health Health Care Infectious Disease Gender Difference Primary Endpoint 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Purpose

Although poorly studied, gender differences can affect the efficacy of HAART. Immigrant women (IW) may also be at risk of treatment failure due to greater marginalization, cultural differences, or reduced access to health care. This subanalysis examined differences in baseline characteristics and response to HAART according to sex and geographic origin.

Methods

Subanalysis of GES-5808 (retrospective comparative study autochthonous/immigrant patients initiating HAART Jan05-Dec06). Late diagnosis was defined as a CD4+ count ≥200, and/or AIDS at initiation of HAART. The primary endpoint was time to treatment failure (TTF), which was defined as virological failure (VF), death, opportunistic infection (OI), interruption of HAART, or loss to follow-up. Survival was analyzed using a univariate (Kaplan-Meier) and multivariate (Cox regression) approach.

Results

Patient Characteristics at Initiation of HAART (Table 1)

Table 1

 

WOMEN (318)

MEN (772)

P

Immigrants, %

45.6

31.1

<0.001

Age, years (IQR)

35 (29-41)

39 (33-44)

<0.001

Median viral load (IQR)/CD4 (IQR)

4.7 (4.2-5.2)/ 217 (113-300)

5.0 (4.5-5.4)/ 190 (69-280)

0.001/0.002

Coinfection with HBV or HCV %

25.2

29.3

0.32

Stage C/Late diagnosis, %

21.2/49.0

29.0/59.0

0.006/0.003

Median time from diagnosis of HIV infection to initiation of HAART, mo (IQR)

15 (2-43)

16 (2-49)

0.55

Median TTF, wk

147

171

<0.001

VF/OI, %

5.3

6.3

0.52

Educational level and occupational status were significantly poorer in women. The adjusted risk of treatment failure in women was not significantly different from that of men (HR, 1.101; 95% CI, 0.79-1.53). The increase in CD4 lymphocytes was equivalent (185 vs 205). TTF was shorter among (IW) than autochthonous women (AW): 124 weeks (95% CI, 64-183) vs 152 (95% CI, 127-174). Most immigrant women were African and Latin American, and their dropout rate (25.5 vs 11.6) was double that of AW.

Conclusions

Response to HAART was similar in both sexes. Men started HAART later and women had higher loss to follow-up and more treatment switches. This was even more common among IW. Earlier diagnosis is necessary for men; measures to improve adherence should be promoted among women, especially IW.

Copyright information

© Perez-Molina et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Authors and Affiliations

  • JA Perez-Molina
    • 1
  • M Mora-Rillo
    • 2
  • I Suarez-Lozano
    • 3
  • JL Casado
    • 4
  • R Teira
    • 5
  • P Rivas
    • 6
  • E Pedrol
    • 7
  • A Hernando
    • 8
  • P Domingo
    • 9
  • E Barquilla
    • 10
  • H Esteban
    • 10
  • J Gonzalez-Garcia
    • 10
  1. 1.Tropical Medicine Unit. Infectious Diseases Dpt.Hospital Ramón y CajalMadridSpain
  2. 2.Hospital La PazMadridSpain
  3. 3.Cohorte VACHHuelvaSpain
  4. 4.Hospital Ramon y CajalMadridSpain
  5. 5.Cohorte VACHTorrelavegaSpain
  6. 6.Hospital Carlos IIIMadridSpain
  7. 7.Cohorte VACHTarragonaSpain
  8. 8.Hospital 12 de OctubreMadridSpain
  9. 9.Cohorte VACHBarcelonaSpain
  10. 10.Fundación SEIMC-GESIDAMadridSpain

Personalised recommendations